Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The TOPGUN Trial: Threshold for Operative and Postoperative Hemoglobin Trigger for Red Blood Cell Transfusion

NCT07748663 is registered in ClinicalTrials.gov with Ottawa Hospital Research Institute as lead sponsor.

NCT NCT07748663
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07748663 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The TOPGUN Trial: Threshold for Operative and Postoperative Hemoglobin Trigger for Red Blood Cell Transfusion
Lead sponsor
Ottawa Hospital Research Institute
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 19, 2026
Completion date
March 31, 2035
Enrollment
5,058 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

perioperative red blood cell transfusion